XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
11. Segment Information Segment Reporting (Tables)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Segment Reporting [Abstract]    
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding operating segments for the three months ended June 30, 2020 and 2019 is as follows (in millions):
Life
Science		Clinical
Diagnostics		Other
Operations
Segment net sales 2020$252.1  $283.2  $1.6  
 2019$212.4  $357.1  $3.1  
Segment net profit (loss)2020$32.7  $16.6  $(0.1) 
 2019$11.4  $42.4  $(0.5) 
 Information regarding operating segments for the six months ended June 30, 2020 and 2019 is as follows (in millions):
Life
Science		Clinical
Diagnostics		Other
Operations
Segment net sales 2020$479.2  $623.4  $5.9  
 2019$428.1  $691.1  $7.4  
Segment net profit (loss)2020$58.0  $62.8  $0.7  
 2019$34.3  $73.2  $(0.6) 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]   The following reconciles total segment profit to consolidated income before income taxes (in millions):
Three Months EndedSix Months Ended
June 30,June 30,
 2020201920202019
Total segment profit $49.2  $53.3  $121.5  $106.9  
Foreign currency exchange losses, net(0.8) (1.2) (1.7) (2.5) 
Net corporate operating and other expense not allocated to segments
(3.2) (2.8) (6.9) (5.7) 
Change in fair market value of equity securities1,183.5  716.4  2,011.2  1,775.6  
Other income (expense), net17.2  3.9  20.5  22.6  
Consolidated income before income taxes$1,245.9  $769.6  $2,144.6  $1,896.9